| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.26 | 4e-05 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-05 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 7e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.24 | 0.0002 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |